Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
TRDA holding history
Entrada Therapeutics, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TRDA overviewAll 13F holders of TRDAFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −31,186−100.0% | Sold out | Holders |
| Q1 2024 | 31,186 | $432.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 31,186 | $517.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 31,186 | $504.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 31,186 | $467.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 31,186 | $444.4K | <0.1% | +5,000+19.1% | Added | Holders |
| Q4 2022 | 26,186 | $354.0K | <0.1% | +26,186 | New | Holders |